| [1] Tanaka S, Tsukada J, Suzuki W, et al. The interleukin-4 enhancer CNS-2 is regulated by Notch signals and controls initial expression in NKT cells and memory-type CD4 T cells[J]. Immunity, 2006,24(6):689-701.[2] Schaerli P, Willimann K, Lang A B, et al. CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function[J]. J Exp Med, 2000,192(11):1553-1562.[3] King C, Tangye S G, Mackay C R.T follicular helper(TFH) cells in normal and dysregulated immune responses[J]. Annu Rev Immunol, 2008,26:741-766.[4] Tangye S G, Ma C S, Brink R, et al. The good, the bad and the ugly-TFH cells in human health and disease[J]. Nat Rev Immunol, 2013,13(6):412-426.[5] Yu D, Rao S, Tsai L M, et al. The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment[J]. Immunity, 2009,3l(3):457-468.[6] Nurieva R I, Chung Y, Martinez G J, et al. Bcl6 mediates the development of T follicular helper cells[J]. Science, 2009,325(5943):1001-1005.[7] Parrish-Novak J, Dillon S R, Nelson A, et al. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function[J]. Nature, 2000,408(6808):57-63.[8] Spolski R, Leonard W J. Interleukin-21: basic biology and implications for cancer and autoimmunity[J]. Annu Rev Immunol, 2008,26:57-79.[9] Hutloff A, Dittrich A M, Beier K C, et al. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28[J]. Nature, 1999,397(6716):263-266.[10] Yoshinaga S K, Whoriskey J S, Khare S D, et al. T-cell co-stimulation through B7RP-1 and ICOS[J]. Nature, 1999,402(6763):827-832.[11] Gigoux M, Shang J, Pak Y, et al. Inducible costimulator promotes helper T-cell differentiation through phosphoinositide 3-kinase[J]. Proc Natl Acad Sci U S A, 2009,106(48):20371-20376.[12] Xu H, Li X, Liu D, et al. Follicular T-helper cell recruitment governed by bystander B cells and ICOS-driven motility[J]. Nature, 2013,496(7446):523-527.[13] Salomonsson S, Larsson P, Tengnér P, et al. Expression of the B cell-attracting chemokine CXCL13 in the target organ and autoantibody production in ectopic lymphoid tissue in the chronic inflammatory disease Sjgren's syndrome[J]. Scand J Immunol, 2002,55(4):336-342.[14] 郭国宁,谢谆怡,陈永文.共抑制分子PD-1的研究进展[J].免疫学杂志,2010,7(4):639-642.[15] Hams E, McCarron M J, Amu S, et al. Blockade of B7-H1(programmed death ligand 1) enhances humoral immunity by positively regulating the generation of T follicular helper cells[J]. J Immunol, 2011,186(10):5648-5655.[16] Craft J E. Follicular helper T cells in immunity and systemic autoimmunity[J]. Nat Rev Rheumatol, 2012,8(6):337-347.[17] Linterman M A, Rigby R J, Wong R K, et al. Follicular helper T cells are required for systemic autoimmunity[J]. J Exp Med, 2009,206(3):561-576.[18] Simpson N, Gatenby P A, Wilson A, et al. Expansion of circulating T cells resembling follicular helper T cells is a fixed phenotype that identifies a subset of severe systemic lupus erythematosus[J]. Arthritis Rheum, 2010,62(1):234-244.[19] Feng X., Wang D, Chen J, et al. Inhibition of aberrant circulating Tfh cell proportions by corticosteroids in patients with systemic lupus erythematosus[J]. PLoS One, 2012,7(12):e51982.[20] Nakou M, Papadimitraki E D, Fanouriakis A, et al. Interleukin-21 is increased in active systemic lupus erythematosus patients and contributes to the generation of plasma B cells[J]. Clin Exp Rheumatol, 2013,31(2):172-179.[21] Terrier B, Costedoat-Chalumeau N, Garrido M, et al. Interleukin 21 correlates with T cell and B cell subset alterations in systemic lupus erythematosus[J]. J Rheumatol, 2012,39(9):1819-1828.[22] Ma J, Zhu C, Ma B, et al.Increased frequency of circulating follicular helper T cells in patients with rheumatoid arthritis[J]. Clin Dev Immunol, 2012,2012:827480.[23] Wang J, Shan Y, Jiang Z, et al. High frequencies of activated B cells and T follicular helper cells are correlated with disease activity in patients with new-onset rheumatoid arthritis[J]. Clin Exp Immunol, 2013,174(2):212-220.[24] Liu R, Wu Q, Su D, et al. A regulatory effect of IL-21 on T follicular helper-like cell and B cell in rheumatoid arthritis[J]. Arthritis Res Ther, 2012,14(6):R255.[25] Greisen S R, Rasmussen T K, Stengaard-Pedersen K, et al. Increased soluble programmed death-1(sPD-1) is associated with disease activity and radiographic progression in early rheumatoid arthritis[J]. Scand J Rheumatol, 2014,43(2):101-108.[26] Tackenberg B, Kruth J, Bartholomaeus J E, et al. Clonal expansions of CD4+ B helper T cells in autoimmune myasthenia gravis[J]. Eur J Immunol, 2007,37(3):849-863.[27] Luo C, Li Y, Liu W, et al. Expansion of circulating counterparts of follicular helper T cells in patients with myasthenia gravis[J]. J Neuroimmunol, 2013,256(1-2):55-61.[28] Shiao Y M, Lee C C, Hsu Y H, et al. Ectopic and high CXCL13 chemokine expression in myasthenia gravis with thymic lymphoid hyperplasia[J]. J Neuroimmunol, 2010,221(1-2):101-106.[29] 王化泉,于虹,江汇娟,等.低危和中危-Ⅰ骨髓增生异常综合征患者外周血滤泡辅助T细胞数量研究[J].中华血液学杂志,2012,33(7):576-577. |
